1. Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration

   • Sheikh Mohammad Fazle Akbar
   • Maumn Al-Mahtab
   • Yoichi Hiasa

   Review 28 April 2011 Pages: 717 - 723

2. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

   • Kentaro Sugano
   • Yasushi Matsumoto
   • Naoki Hiramatsu

   Original Article—Alimentary Tract Open access 16 April 2011 Pages: 724 - 735

   

3. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk

   • Mitsuru Kaise
   • Jun Miwa
   • Hisao Tajiri

   Original Article—Alimentary Tract 01 April 2011 Pages: 736 - 745

   

4. Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study

   • Takumi Kawaguchi
   • Naoto Shiba
   • Michio Sata

   Original Article—Liver, Pancreas, and Biliary Tract 22 February 2011 Pages: 746 - 757

   

5. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy

   • Naoki Tanaka
   • Akira Horiuchi
   • Eiji Tanaka

   Original Article—Liver, Pancreas, and Biliary Tract 26 January 2011 Pages: 758 - 768

   

6. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period

   • Ayaka Hamabe
   • Hirofumi Uto
   • Hirohito Tsubouchi

   Original Article—Liver, Pancreas, and Biliary Tract 08 February 2011 Pages: 769 - 778

   

7. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells

   • Hiroaki Sugiyama
   • Kenichiro Onuki
   • Junichi Shoda

   Original Article—Liver, Pancreas, and Biliary Tract 18 February 2011 Pages: 779 - 789

   

8. Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C

   • Hirokazu Takahashi
   • Toshihiko Mizuta
   • Kazuma Fujimoto

   Original Article—Liver, Pancreas, and Biliary Tract 18 February 2011 Pages: 790 - 798

   

9. Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy

   • Yuko Nagaoki
   • Hiroshi Aikata
   • Kazuaki Chayama

   Original Article—Liver, Pancreas, and Biliary Tract 04 March 2011 Pages: 799 - 808

   

10. Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma

    • Masayasu Jo
    • Taichiro Nishikawa
    • Toshikazu Yoshikawa

    Original Article—Liver, Pancreas, and Biliary Tract 31 March 2011 Pages: 809 - 821

    

11. Pomalidomide suppresses cerulein-induced acute pancreatitis in mice

    • Ming Jen Tsai
    • Chinpiao Chen
    • Ted H. Chiu

    Original Article—Liver, Pancreas, and Biliary Tract 25 March 2011 Pages: 822 - 833

    

12. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids

    • Kensuke Kubota
    • Seitaro Watanabe
    • Atsushi Nakajima

    Original Article—Liver, Pancreas, and Biliary Tract 15 April 2011 Pages: 834 - 842

    

13. EUS elastography combined with the strain ratio of tissue elasticity for diagnosis of solid pancreatic masses

    • Fumihide Itokawa
    • Takao Itoi
    • Akihiko Tsuchida

    Original Article—Liver, Pancreas, and Biliary Tract 20 April 2011 Pages: 843 - 853